Cite
HARVARD Citation
Teusink‐Cross, A. et al. (2020). Ibrutinib for the treatment of chronic graft‐vs‐host disease in pediatric hematopoietic stem cell transplant patients: A single‐center experience. Pediatric transplantation. p. n/a. [Online].